Msbio엠에스바이오
0013Y0 · KOSDAQ · ₩0013Y0 · 엠에스바이오
- Market cap
- ₩319B
- Enterprise value
- —
- P/E
- —
- P/B
- —
- Dividend yield
- —
- ROE
- —
- Net margin
- —
Financial statements not available yet.
52-week range−40.3% from the high
₩9,510Today: ₩9,900 – ₩13,380₩19,650
Returns
- 1W—
- 1M—
- 3M—
- 6M—
- YTD−11.9%
- 1Y—
- Volume today
- 25,284,909
- 0.8× the 20-day average
- Traded today
- ₩306B
- Listed shares
- 27,202,650
- EPS (12 months)
- —
🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Why is it moving?
+8.9% on Oct 27, 2026.
Msbio filed a prospectus and amended securities registration documents in late September and early October 2026, then amended the prospectus again on October 7. Shareholding reports were filed on October 28, but the sources do not describe their contents. The December 2025 audit report was filed in April 2026.
AI summary of the news and filings linked. It can be wrong; check them.
- • Filing: Insider shareholding report
- • Filing: 5%+ holding report
- • Foreign investors bought a net ₩65M that day
Possible reasons, not certainties. Not financial advice.
Signals
Normal- BuzzNormalBuzz 47 of 100 (50 is a normal day for this stock).
- SentimentMixedNews: Routine filings only, with no clear positive or negative news. Community: 0 bullish, 0 bearish posts this week.
- News impactLow2 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Msbio stock overview
Msbio (엠에스바이오, KRX: 0013Y0) is listed on KOSDAQ, in the Medical & precision devices sector. Its shares closed at ₩11,740 on Oct 27, 2026, up 8.91% on the day, giving it a market value of ₩319B.
Key facts
- Market cap
- ₩319B
- Sector
- Medical & precision devices
- Latest price change
- +8.91%
- As of
- Oct 27, 2026
Quick answers about Msbio
- What is the market cap of Msbio?
- The market capitalisation of Msbio was ₩319B at the close on Oct 27, 2026.
- Who are the largest shareholders of Msbio?
- According to the latest official filings, the largest reported holders are 뉴메인 휴먼 더마텍 신기술투자조합 (8.22%, as of Oct 28, 2026).
Company profile
Loading data for this company — check back soon
- Korean name
- 엠에스바이오
- Themes
- Medical devices
- CEO
- 김성포
- Founded
- Oct 2015
- Listed
- Oct 2026
- Listed shares
- 27,202,650
- Fiscal year ends
- Month 12
- Website
- www.msbio.co.kr/
Similar companies
- TSE131290 · ₩2.9T₩260,000+7.88%
- Kctech281820 · ₩1.8T₩91,900+6.37%
- Classys214150 · ₩1.7T₩26,500−2.57%
- Park Systems140860 · ₩1.6T₩225,500+1.12%
- Curiox Biosystems445680 · ₩1.1T₩62,300+6.13%
- DI003160 · ₩1.1T₩37,800+4.71%
- Seers458870 · ₩1T₩26,300−5.57%
- LivsMed491000 · ₩937B₩37,100+1.50%
Recent filings
See all- Insider shareholding reportOct 28, 2026
- 5%+ holding reportOct 28, 2026
- Amended: ProspectusOct 7, 2026
- Terms set: Securities registration statementOct 7, 2026
- ProspectusOct 1, 2026
Titles in Korean until English translations are added.
Also known as: Msbio / 엠에스바이오 / 0013Y0 / KRX:0013Y0
Source: KRX statistical information